Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial.
The lancet. Diabetes & endocrinology（2023）
摘要
Novo Nordisk.
更多查看译文
关键词
diabetes,once-weekly,once-daily,insulin-treated,treat-to-target
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要